Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer’s Disease Using Metabolomics

Alzheimer’s Disease (AD) currently affects more than 5 million Americans, with numbers expected to grow dramatically as the population ages. The pathophysiological changes in AD patients begin decades before the onset of dementia, highlighting the urgent need for the development of early diagnostic...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Trushina, Eugenia, Dutta, Tumpa, Persson, Xuan-Mai T., Mielke, Michelle M., Petersen, Ronald C.
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2013
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3658985/
https://ncbi.nlm.nih.gov/pubmed/23700429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0063644
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares